RhLAL: Interim Phase I/II data

Interim data from an open-label, international Phase I/II trial in 9 patients with liver dysfunction due to late onset LAL deficiency showed that 4 weekly infusions of 0.35, 1 or 3 mg/kg SBC-102 were ...